Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Cys2His2 (C2H2) zinc finger DNA-binding domain is the most common DNA-binding motif found in eukaryotic transcription factors, characterized by a consensus sequence where a zinc ion is coordinated by two cysteine and two histidine residues (UniProt: PRO_0000044506). These domains typically consist of an alpha-helix and a two-stranded beta-sheet, where the alpha-helix inserts into the major groove of the DNA to recognize specific nucleotide triplets (PubMed: 15718139). Beyond DNA binding, C2H2 domains can also mediate RNA binding and protein-protein interactions, making them versatile regulators of gene expression and cellular signaling (PubMed: 23395138). In therapeutic contexts, C2H2 domains have been extensively engineered to create Zinc Finger Nucleases (ZFNs) for precision genome editing and artificial transcription factors for gene modulation (PubMed: 20871606). Dysregulation or mutation of proteins containing these domains is linked to various pathologies, including oncogenesis, where they may act as either activators or repressors of tumor-related genes (PubMed: 28231538). While highly specific, the primary challenge in targeting or utilizing these domains remains the risk of off-target effects and the complexity of designing domains for non-canonical DNA sequences.
Engineered C2H2-ZNF domains are used in Zinc Finger Nucleases (ZFNs) to induce site-specific double-strand breaks for gene editing (PubMed: 20871606). Small molecules can also disrupt the coordination of the zinc ion or compete for DNA binding sites (PubMed: 15575857).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cys2His2 zinc finger DNA-binding domain (C2H2-ZNF).